Regulus Therapeutics Surges on Positive Phase 1b Results and Oversubscribed Private Placement
Regulus Therapeutics Phase 1b Trial Results Regulus Therapeutics Inc announces promising topline results from the second cohort of patients in its Phase 1b multiple-ascending dose
